(Q33442816)

English

Are the effects of alpha-glucosidase inhibitors on cardiovascular events related to elevated levels of hydrogen gas in the gastrointestinal tract?

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 July 2017

Are the effects of alpha-glucosidase inhibitors on cardiovascular events related to elevated levels of hydrogen gas in the gastrointestinal tract? (English)

1 reference

Europe PubMed Central

26 July 2017

circulatory system

1 reference

based on heuristic

inferred from title

Kentaro Hayashida

object named as

Kentaro Hayashida

3

0 references

author name string

Yoshihiko Suzuki

1

1 reference

Europe PubMed Central

26 July 2017

Motoaki Sano

2

1 reference

Europe PubMed Central

26 July 2017

Ikuroh Ohsawa

4

1 reference

Europe PubMed Central

26 July 2017

Shigeo Ohta

5

1 reference

Europe PubMed Central

26 July 2017

Keiichi Fukuda

6

1 reference

Europe PubMed Central

26 July 2017

language of work or name

0 references

publication date

6 June 2009

1 reference

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

26 July 2017

583

1 reference

Europe PubMed Central

26 July 2017

13

1 reference

Europe PubMed Central

26 July 2017

2157-2159

1 reference

Europe PubMed Central

26 July 2017

The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.05.052

21 January 2018

Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men. The Rancho Bernardo Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.05.052

21 January 2018

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.05.052

21 January 2018

Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.05.052

21 January 2018

Oxidative stress in atherogenesis and arterial thrombosis: the disconnect between cellular studies and clinical outcomes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.05.052

21 January 2018

Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance?

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.05.052

21 January 2018

Redox regulation of the afferent arteriole and tubuloglomerular feedback

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.05.052

21 January 2018

Why have antioxidants failed in clinical trials?

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.05.052

21 January 2018

Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.05.052

21 January 2018

Inhalation of hydrogen gas reduces infarct size in the rat model of myocardial ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.05.052

21 January 2018

Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.05.052

21 January 2018

A role for oxidized phospholipids in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.05.052

21 January 2018

Consumption of hydrogen water prevents atherosclerosis in apolipoprotein E knockout mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.05.052

21 January 2018

Production and excretion of hydrogen gas in man.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.05.052

21 January 2018

Effects of alpha-glucosidase inhibitors on mouth to caecum transit time in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.05.052

21 January 2018

Identifiers

10.1016/J.FEBSLET.2009.05.052

1 reference

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33442816&oldid=1536136735"